Navidea Biopharmaceuticals, Inc. (AMEX: NAVB) announced that it has priced an underwritten sale of common stock in a transaction involving ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE